Found 69 matching trials
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer NA Clinicians are currently proposing second-line hormonal treatment to a meta...
Show More Location
Institut de Cancerologie de l'Ouest
Learn More & Join Trial
16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer PHASE1 Breast cancer (BC) is the most common cancer diagnosis among women and the ...
Show More Location
Department of Nuclear Medicine & PET Centre, Aarhus University Hospital
Learn More & Join Trial
[18F]FES PET/CT in PAH N/A In this study positron emission tomography (PET/CT) imaging will be used to...
Show More Location
University of Pennsylvania Hospital
Learn More & Join Trial
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma PHASE2 FES PET/CT imaging for invasive lobular cancer...
Location
Huntsman Cancer Institute
Learn More & Join Trial
Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI PHASE2 Purpose: The primary objective is to evaluate the sensitivity and specifici...
Show More Learn More & Join Trial
FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET NA Accurate staging is of great importance in patients with clinically locally...
Show More Location
VU University Medical Center
Learn More & Join Trial
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer N/A The purpose of this study to compare two types of cancer imaging scans to s...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
FES-PET for Patients Treated on NCI Protocol 8762 NA A significant number of all invasive breast cancers are hormone sensitive a...
Show More Location
Mallinckrodt Institute of Radiology
Learn More & Join Trial
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer PHASE2 This phase II trial studies how well a vaccine, STEMVAC, works in combinati...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor N/A To investigate the treatment pattern and efficacy of patients with negative...
Show More Learn More & Join Trial